Research | Hadassah International

Hadassah International Supports the Hadassah Medical Center: More than a Hospital!

Enlivex Reports Top-Line Results for Allocetra™ in Treating COVID-19

Enlivex, the Israeli biomedical company, has reported “positive top-line results” for its Phase II clinical trial of Allocetra™ to treat COVID-19. The study, led by Prof. Vernon van Heerden, head…

...More than a Hospital

Hadassah and Neurogenesis Announce Groundbreaking Results From Phase 2 MS Study

Drug Developed by Hadassah Doctor Helps Severely Ill COVID-19 Patients

...More than a Hospital

Hadassah Explores Link Between Levels of Anxiety and Eating Sweets

...More than a Hospital

Using Algorithms, Israeli Start-Up Predicts Who Has COVID-19

...More than a Hospital

Hadassah to Conduct Clinical Trial of Israeli-Made COVID-19 Vaccine

...More than a Hospital

Sperm Quality Reduced in Lymphoma Patients, Hadassah Study Reveals

...More than a Hospital

Hadassah Physician-Scientists Are Showcased at Global Press Conference

...More than a Hospital

Hadassah Physician Turns to SodaStream to Ease COVID-19 Patients’ Breathing

...More than a Hospital

Six Hadassah Researchers Receive Major Grants From Israel Science Foundation

...More than a Hospital

A Devoted Hadassah Geneticist and the Mexican Jewish Community Project

...More than a Hospital

First Commercial Antibody Serum Given at Hadassah to COVID-19 Patient

...More than a Hospital

Hadassah Study Debunks Notion About Timing of Epidurals During Labor

...More than a Hospital

Hadassah Researchers Identify Source of Blood Clots in COVID-19 Patients

First in the World

Hadassah Pediatric Nephrologists Discover Way to Prevent Kidney Disease

COVID-19: Can We Win the War?

...More than a Hospital

Has COVID-19 Changed the Nature of Social Interaction for Good?

...More than a Hospital

Hadassah Doctor to Study Link Between Sleep Apnea and Diabetes

...More than a Hospital

“What is Next?” – Hadassah Doctors Bring their COVID-19 Expertise to Russia

On the Way to a Cure for COVID-19: Hadassah’s Researchers Forge Ahead